Anti-Cancer Drugs Journal Issues Research Articles in March 2022 Edition
February 14, 2022
February 14, 2022
LONDON, England, Feb. 14 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its March 2022 edition:
Original Studies:
* Heat shock protein 47 promotes cell migration and invasion through AKT signal in non- . . .
Original Studies:
* Heat shock protein 47 promotes cell migration and invasion through AKT signal in non- . . .
